Abstract P3-05-06: A nude mouse model of diet-induced-obesity to study the mechanisms of resistance to aromatase inhibitor letrozole in MCF-7Ca xenografts

Obesity has been identified as one of the risk factor for breast cancer progression. However the mechanisms underlying this link are not completely understood. Specifically, breast cancer patients who are overweight, obese or have excess abdominal fat have increased risk of local or distant (metastasis) recurrence and cancer related death. Furthermore, breast cancer patients gain weight during treatment, especially those who receive hormone depletion therapies, are at increased risk of developing obesity and metabolic syndrome as survivors. Importantly, the presence of obesity may influence the resistance of breast cancer to existing treatments, such as aromatase inhibitors (AIs). In an effort to understand the effect of obesity on the growth of hormone dependent breast cancer tumors, we fed ovariectomized athymic nude mice a diet containing 45% kcal fat (45% of the total calories coming from the fat in the diet) and low fat (10% kcal fat) diet. We also used a standard chow diet to compare with our previous results. We saw that mice fed 45%kcal fat diet had a higher rate of tumor growth (p=0.04) compared to mice that were fed 10% kcal fat containing diet or chow diet. In addition, the mice fed 45% kcal fat had higher body weight, fasting insulin (as measured by C-peptide ELISA) and high fasting glucose levels. Glucose tolerance test (IP-GTT) demonstrated that mice fed high fat diet exhibited reduced glucose tolerance as measured by high AUC glucose in high fat versus low fat or chow diet. There was no statistically significant difference between the chow diet and the low fat diet. Next, we examined the effect of insulin on the growth of MCF-7Ca cells in response to E 2 or letrozole. When co-treated with 2μM of exogenous insulin (in otherwise serum starved condition), the growth of MCF-7Ca cells was not stimulated by E 2 at 1nM. However, at lower does, the combination of insulin with E 2 stimulated cell growth more than E 2 alone. This suggests that insulin makes MCF-7Ca breast cancer cells hypersensitive to mitogenic effects of E 2 . Hypersensitivity to E 2 is one of the suggested mechanisms of resistance to endocrine therapy. Furthermore, response to anti-proliferative effects of letrozole was also abrogated in presence of insulin (2μM). This was more pronounced at lower dose of letrozole. These results suggest that the presence of insulin makes MCF-7Ca cells less responsive to E 2 and letrozole. Furthermore, tumors of mice fed with high-fat diet also had higher activation of MAPK and Akt, suggesting induction of growth factor receptor pathways. Exogenous insulin treatment of MCF-7Ca cells also resulted in reduction of ERα protein levels and increase in p-IR, p-IGFR and p-Akt. These results suggest that diet-induced obesity may result in acquisition of resistance to letrozole due to development of hyperinsulinemia. We hypothesized that the presence of obesity can augment adaptation of cancer cells and impact the mechanism. This may be the result of a dramatically different hormonal milieu upon development of obesity. Citation Format: Amanda Schech, Stephen Yu, Preeti Shah, Olga Goloubeva, Angela Brodie, Saranya Chumsri, Gauri Sabnis. A nude mouse model of diet-induced-obesity to study the mechanisms of resistance to aromatase inhibitor letrozole in MCF-7Ca xenografts [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2014 Dec 9-13; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2015;75(9 Suppl):Abstract nr P3-05-06.